Report finds new approved patented medicines have high treatment costs

By Anosha Khan (August 23, 2023, 12:49 PM EDT) -- The Patented Medicine Prices Review Board (PMPRB) published its seventh edition of its annual Meds Entry Watch Report, which found that the number of new medicines launched in Canada was higher than the median for Organisation for Economic Co-operation and Development (OECD) countries....

Related Sections